ArticleHRB open research2020

Interpreting cost-effectiveness ratios in a cost-effectiveness analysis of risk-tailored prostate screening: A critique of Callender

James F O'MahonyPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.